Personalized Medicine & Genetics
Personalized medicine uses genetic information to guide prevention, diagnosis, and treatment decisions. At Agave Biomedical, we focus on the genetic foundations of disease so that therapies can be selected around the biology of individual patients rather than applied uniformly.
Pharmacogenomics
We study how individual genetic variation influences response to medicines, aiming to reduce adverse reactions and identify patients most likely to benefit from a given therapy.
Genetic biomarker development
From somatic tumor mutations to inherited risk variants, we work to translate genetic signals into clinically useful biomarkers that guide treatment selection and monitoring.
Companion diagnostics
We explore diagnostic approaches that pair a specific genetic test with a targeted therapy, helping clinicians match the right intervention to the right patient profile.
Precision trial design
By enriching clinical study populations with genetic or molecular criteria, we aim to improve the likelihood that promising therapies demonstrate clear benefit in well-defined patient groups.
How this connects to our other work
Personalized medicine sits at the intersection of everything we do. Candidate targets come from genomics, therapies are developed through drug discovery, the right patients are identified with diagnostics and biomarkers, and equitable access is shaped by our public health work. In oncology, neurology, and neurodegeneration, we believe genetic guidance is essential to the next generation of patient care.